Propranolol-magnesium aluminum silicate complex dispersions and particles: characterization and factors influencing drug release.

[1]  Hasmukh A. Patel,et al.  Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. , 2009, International journal of pharmaceutics.

[2]  S. Puttipipatkhachorn,et al.  Physicochemical characterizations and release studies of nicotine–magnesium aluminum silicate complexes , 2009 .

[3]  S. Neau,et al.  Pellet characteristics and drug release when the form of propranolol is fixed as moles or mass in formulations for extruded and spheronized Carbopol-containing pellets. , 2009, International journal of pharmaceutics.

[4]  R. Heyrovská.  Golden sections of inter-atomic distances as exact ionic radii of atoms , 2009 .

[5]  T. Pongjanyakul,et al.  Interaction of nicotine with magnesium aluminum silicate at different pHs: characterization of flocculate size, zeta potential and nicotine adsorption behavior. , 2008, Colloids and surfaces. B, Biointerfaces.

[6]  Y. B. Choy,et al.  Controlled release of donepezil intercalated in smectite clays. , 2008, International journal of pharmaceutics.

[7]  Z. Ni,et al.  RETRACTED: Synthesis, characterization and release of curcumin-intercalated Mg–Al-layered double hydroxides , 2008 .

[8]  S. Sahoo,et al.  Comparative Study of Propranolol hydrochloride Release from Matrix Tablets with Kollidon®SR or Hydroxy Propyl Methyl Cellulose , 2008, AAPS PharmSciTech.

[9]  A. C. Fernandes,et al.  Loading and delivery of sertraline using inorganic micro and mesoporous materials. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  C. Caramella,et al.  Use of clays as drug delivery systems: Possibilities and limitations , 2007 .

[11]  C. Viseras,et al.  Uses of clay minerals in semisolid health care and therapeutic products , 2007 .

[12]  D. Ghanotakis,et al.  Intercalation of hydrophilic and hydrophobic antibiotics in layered double hydroxides. , 2007, International journal of pharmaceutics.

[13]  E. Gil,et al.  Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride. , 2006, International journal of pharmaceutics.

[14]  A. Bandara,et al.  Determination of the adsorption process of tributyltin (TBT) and monobutyltin (MBT) onto kaolinite surface using Fourier transform infrared (FTIR) spectroscopy , 2005 .

[15]  A. Kibbe.  Handbook of Pharmaceutical Excipients , 2003 .

[16]  S. Ray,et al.  New polylactide/layered silicate nanocomposites. 3. High-performance biodegradable materials , 2003 .

[17]  R. Bogner,et al.  Formation of physically stable amorphous drugs by milling with Neusilin. , 2003, Journal of pharmaceutical sciences.

[18]  Haydn H. Murray,et al.  Traditional and new applications for kaolin, smectite, and palygorskite: a general overview , 2000 .

[19]  P. Dubois,et al.  Polymer-layered silicate nanocomposites: preparation, properties and uses of a new class of materials , 2000 .

[20]  R. Kirkpatrick,et al.  Electronic and structural properties of reduced-charge montmorillonites , 2000 .

[21]  Bergaya,et al.  Effect of pH on Rheological Properties of Purified Sodium Bentonite Suspensions. , 1999, Journal of colloid and interface science.

[22]  Raymond C Rowe,et al.  Handbook of Pharmaceutical Excipients , 1994 .

[23]  Bruce Velde,et al.  Introduction to clay minerals , 1992 .

[24]  R. Murthy,et al.  Novel method to evaluate diffusion controlled release of drug from resinate , 1986 .

[25]  M. S. Camazano,et al.  Interaction of propranolol hydrochloride with montmorillonite , 1981, The Journal of pharmacy and pharmacology.

[26]  R. E. Smallman,et al.  An assessment of high voltage electron microscopy (HVEM). An invited review , 1977 .

[27]  J. Mcginity,et al.  Sustained-release applications of montmorillonite interaction with amphetamine sulfate. , 1977, Journal of pharmaceutical sciences.